Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke

Experimental Neurology

Volumn 236, Issue 1, 2012, Pages 122-130

  Bazan, Nicolas G ^a   Eady, Tiffany N ^a   Khoutorova, Larissa ^a   Atkins, Kristal D ^a   Hong, Song ^a   Lu, Yan ^a   Zhang, Changde ^a   Jun, Bokkyoo ^a   Obenaus, Andre ^b   Fredman, Gabrielle ^c   Zhu, Min ^d   Winkler, Jeremy W ^d   Petasis, Nicos A ^d   Serhan, Charles N ^c   Belayev, Ludmila ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Aspirin; Behavior; Cerebral ischemia; Docosahexaenoic acid; Histopathology; Middle cerebral artery occlusion; Neuroprotectin D1; Rat; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; DIHYDROXY DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOIC ACID; GLUCOSE; SODIUM; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; BRAIN CORTEX; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN SIZE; BRAIN TEMPERATURE; CONTROLLED STUDY; CORPUS STRIATUM; DIFFUSION COEFFICIENT; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG SYNTHESIS; EX VIVO STUDY; GLUCOSE BLOOD LEVEL; MALE; MENTAL HEALTH; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC EXAMINATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; RECTUM TEMPERATURE; SCORING SYSTEM; SPRAGUE DAWLEY RAT; STROKE; SUBCORTEX; WATER CONTENT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BRAIN ISCHEMIA; DOCOSAHEXAENOIC ACIDS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84861696925     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.04.007     Document Type: Article

References (34)

1. Bazan N.G. Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci. 2006, 29:263-271.
2. Bazan N.G. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10:136-141.
3. Bazan N.G., Marcheselli V.L., Lu Y., Hong S., Jackson F. Lipidomic approaches to neuroprotection signaling in the retinal pigement epithelium. Signal Transduction in the Retina 2008, 349-373. CRC Press. S.J. Fliesler, O.G. Kisselev (Eds.).
4. Bazan N.G., Calandria J.M., Serhan C.N. Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1. J. Lipid Res. 2010, 51:2018-2031.
5. Belayev L., Alonso O.F., Busto R., Zhao W., Ginsberg M.D. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 1996, 27:1616-1622.
6. Chiang N., Bermudez E.A., Ridker P.M., Hurwitz S., Serhan C.N. Aspirin triggers anti-inflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:15178-15183.
7. Clària J., Serhan C.N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:9475-9479.
8. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
9. Donnan G.A., Baron J.C., Ma H., Davis S.M. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol. 2009, 8:261-269.
10. Ebinger M., De Silva D.A., Christensen S., Parsons M.W., Markus R., Donnan G.A., Davis S.M. Imaging the penumbra - strategies to detect tissue at risk after ischemic stroke. J. Clin. Neurosci. 2009, 16:178-187.
11. Iadecola C., Anrather J. The immunology of stroke: from mechanisms to translation. Nat. Med. 2011, 17:796-808.
12. Kakar P., Watson T., Lip G.Y. New approaches to therapy with omega-3 fatty acids. Curr. Atheroscler. Rep. 2008, 10:79-87.
13. Kaufmann W.E., Worley P.F., Pegg J., Bremer M., Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:2317-2321.
14. Le Bihan D., Mangin J.F., Poupon C., Clark C.A., Pappata S., Molko N., Chabriat H. Diffusion tensor imaging: concepts and applications. J. Magn. Reson. Imaging 2001, 13:534-546.
15. Li L., Jiang Q., Ding G., Zhang L., Li Q., Panda S., Kapke A., Lu M., Ewing J.R., Chopp M. MRI identification of white matter reorganization enhanced by erythropoietin treatment in a rat model of focal ischemia. Stroke 2009, 40:936-941.
16. Lo E.H. A new penumbra: transitioning from injury into repair after stroke. Nat. Med. 2008, 14:497-500.
17. Marcheselli V.L., Hong S., Lukiw W.J., Tian X.H., Gronert K., Musto A., Hardy M., Gimenez J.M., Chiang N., Serhan C.N., Bazan N.G. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 2003, 278:43807-43817.
18. Mogoantǎ L., Pirici D., Pop O.T., Bǎlşeanu A.T., Rolea E., Dahnovici R.M. Study of vascular microdensity in areas of cerebral ischemia on experimental model. Rom. J. Morphol. Embryol. 2010, 51:725-731.
19. Moskowitz M.A., Lo E.H., Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010, 67:181-198.
20. Mukherjee P.K., Marcheselli V.L., Serhan C.N., Bazan N.G. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:8491-8496.
21. Panickar K.S., Norenberg M.D. Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 2005, 50:287-298.
22. Ratan R.R. Beyond neuroprotection to brain repair: exploring the next frontier in clinical neuroscience to expand the therapeutic window for stroke. Transl. Stroke Res. 2010, 1:71-73.
23. Rowlinson S.W., Crews B.C., Goodwin D.C., Schneider C., Gierse J.K., Marnett L.J. Spatial requirements for 15-(R)-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid synthesis within the cyclooxygenase active site of murine COX-2. J. Biol. Chem. 2000, 275:6586-6591.
24. Schwab J.M., Chiang N., Arita M., Serhan C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007, 447:869-874.
25. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., Moussignac R.L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J. Exp. Med. 2002, 196:1025-1037.
26. Serhan C.N., Gotlinger K., Hong S., Lu Y., Siegelman J., Baer T., Yang R., Colgan S.P., Petasis N.A. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 2006, 176:1848-1859.
27. Serhan C.N., Fredman G., Yang R., Karamnov S., Belayev L.S., Bazan N.G., Zhu M., Winkler J.W., Petasis N.A. Novel proresolving aspirin-triggered DHA pathway. Chem. Biol. 2011, 18:976-987.
28. Stark D.T., Bazan N.G. Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer's disease cellular models. Mol. Neurobiol. 2011, 43:131-138.
29. Stark D.T., Bazan N.G. Synaptic and extrasynaptic NMDA receptors differentially modulate cyclooxygenase-2 function, lipid peroxidation, and neuroprotection. J. Neurosci. 2011, 31:13710-13721.
30. Sun S.W., Neil J.J., Song S.K. Relative indices of water diffusion anisotropy are equivalent in live and formalin-fixed mouse brains. Magn. Reson. Med. 2003, 50:743-748.
31. Takano T., Fiore S., Maddox J.F., Brady H.R., Petasis N.A., Serhan C.N. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 1997, 185:1693-1704.
32. Thompson S.N., Gibson T.R., Thompson B.M., Deng Y., Hall E.D. Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice. Exp. Neurol. 2006, 201:253-265.
33. Tu B., Bazan N.G. Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp. Neurol. 2003, 179:167-175.
34. Yip S., Benavente O. Antiplatelet agents for stroke prevention. Neurotherapeutics 2011, 8:475-487.